Locust Walk company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

locustwalk.com

About Locust Walk

Locust Walk is a global life science transaction firm that integrates strategy, market analytics, and transaction capabilities from both biopharma and medtech perspectives on a global scale. The company is based in Boston, Massachusetts.

Locust Walk Headquarter Location

200 Clarendon Street 51st Floor

Boston, Massachusetts, 02116,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Locust Walk News

Neurona Therapeutics to Present at the Locust Walk Stem Cell Tx Conference

Apr 4, 2022

South San Francisco, California, UNITED STATES SAN FRANCISCO, April 04, 2022 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapies to treat chronic neurological disorders, today announced that Cory R. Nicholas, Ph.D., Neurona’s president and chief executive officer will present a corporate overview at the Locust Walk Stem Cell Tx Conference, which is being organized in partnership with the Harvard Stem Cell Institute, on April 11, 2022, at 3:00 PM ET. The event will be webcast live and may be accessed via a link on the News and Events  section of the Neurona website. An archived copy of the webcast will be available on the Neurona website for approximately 30 days after the event. About Neurona Neurona’s regenerative neural cell therapies have single-dose curative potential. Based on a novel neural cell lineage developed by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing off-the-shelf, allogeneic neuronal, glial, and gene-edited cell therapy candidates that provide long-term integration and repair of dysfunctional neural networks for multiple neurological disorders. Neurona’s lead product candidate, NRTX-1001, a targeted inhibitory neuron cell therapy derived from human pluripotent stem cells, is designed to repair hyperexcitable neural networks that underlie epilepsy, as well as other disorders of the nervous system, and is being evaluated for safety and efficacy in a Phase 1/2 multicenter clinical trial in people with drug-resistant mesial temporal lobe epilepsy. For more information, please visit clinicaltrials.gov (NCT05135091) . More information about Neurona can be found at www.neuronatherapeutics.com Neurona Therapeutics

Locust Walk Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Locust Walk Rank

  • Where is Locust Walk's headquarters?

    Locust Walk's headquarters is located at 200 Clarendon Street, Boston.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.